Announcement on the Approval of Gecacitinib Hydrochloride Tablets for Marketing

About this update from Suzhou Zelgen Biopharmaceuticals Co. Ltd. Class A

Announcement on the Approval of Gecacitinib Hydrochloride Tablets for Marketing The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Suzhou Zelgen Biopharmaceuticals Co. Ltd. Class A